Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected - PubMed (original) (raw)

Review

Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpected

Oliver Stoeltzing et al. Cancer Cell. 2006 Aug.

Free article

Abstract

In this issue of Cancer Cell, Phung and coworkers demonstrate that sustained endothelial activation of Akt by expression of constitutively activated Akt1 (myrAkt1) leads to blood vessels that essentially recapitulate the complex structural and functional abnormalities of tumor vessels. The authors provide evidence that rapamycin inhibition of PI3K/Akt/mTOR signaling in endothelial cells (ECs), by either reducing Akt activity or blocking mTOR, reverses the pathologic effects associated with excess VEGF signaling in the tumor vasculature. However, unexpected findings following mTOR inhibition in vivo highlight the seemingly paradoxical and complex effects of rapamycin on various cell types within the tumor microenvironment.

PubMed Disclaimer

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources